Materials • Major Chemicals
$133.06 ▼ -7.27
(-5.18%)
MKT CAP: $2.50B • VOL: 175.4K
52W L $75 52W H $169
ROARABLE / RQD
D • 51/100
PIOTROSKI
5 / 9
ROG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $810.8M | $830.1M | $908.4M |
| YoY Revenue Growth % | -2.3% | -8.6% | — |
| Gross Profit | $256.8M | $277.1M | — |
| Gross Margin % | 31.7% | 33.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$45.0M | $24.9M | $85.3M |
| Operating Margin % | -5.6% | 3.0% | 9.4% |
| Net Income (GAAP) | -$61.8M | $26.1M | $56.6M |
| EBITDA (Normalized) | -$20.9M | $69.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $101.2M | $127.1M | $131.4M |
| Capital Expenditures (CapEx) | $30.1M | $56.1M | — |
| Free Cash Flow (FCF) | $71.1M | $71.0M | $131.4M |
| FCF Margin % | 8.8% | 8.6% | 14.5% |
| Return on Invested Capital (ROIC %) | -3.6% | 1.8% | — |
| Cash & Short-Term Equivalents | $197.0M | $159.8M | — |
| Total Debt (Short + Long Term) | — | $0 | — |
| Total Stockholders' Equity | $1.20B | $1.25B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ROG.